Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07361302
PHASE3

A Study to Test if Tenecteplase Helps People to Recover From an Acute Stroke When Given More Than 4.5 Hours After the Person Was Last Seen Well

Sponsor: Boehringer Ingelheim

View on ClinicalTrials.gov

Summary

This study is open to adults who had an acute stroke caused by a clot blocking a blood vessel in the brain (acute ischemic stroke). This study is for people who had an acute stroke or woke up with a stroke and were last seen well more than 4.5 hours before joining the study. Participants need to have imaging that shows there is brain tissue that can still be saved. They also should not be planned to receive a procedure to remove the blood clot. The purpose of this study is to find out whether a medicine called tenecteplase helps people recover from an acute stroke. Tenecteplase is already used to treat people within 4.5 hours after they had a stroke. This study tests if tenecteplase also helps if it is given more than 4.5 hours after the stroke. Participants are put into 2 groups randomly, which means by chance. One group gets tenecteplase as a single injection into a vein. The other group receives standard medical practice. Participants have an equal chance of receiving tenecteplase or the standard treatment. Participants are in the study for about 3 months. In the beginning, participants stay in the hospital for about 1 week. During the study, participants have 7 clinical examinations or visits. The last 2 of these visits will likely be done from home, allowing participants to complete certain assessments remotely. Doctors regularly test participants' recovery using a scale that measures the level of disability or dependence in daily activities. The results are compared between the 2 groups to see whether the treatment works. The doctors also check participants' health and take note of any unwanted effects.

Official title: TENACITY - A Phase III, Prospective, Randomized, Open-label, Blinded Endpoint Assessment (PROBE) to Assess Efficacy and Safety of i.v. Tenecteplase vs Standard of Care in Patients With Acute Ischemic Stroke (Including Wake-up Stroke), Last Known Well >4.5 h With Imaging Evidence of Salvageable Ischemic Tissue

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

1325

Start Date

2026-02-17

Completion Date

2027-10-02

Last Updated

2026-10-27

Healthy Volunteers

No

Interventions

DRUG

Tenecteplase

Tenecteplase

DRUG

Standard of care treatment

Standard of care treatment

Locations (257)

Sanatorio Güemes

Buenos Aires, Argentina

Hospital Italiano de Buenos Aires

Ciudad Autonoma Buenos Aires, Argentina

CEMIC

Ciudad Autonoma Buenos Aires, Argentina

Hospital General de Agudos Dr. J. M. Ramos Mejia

Ciudad Autonoma Buenos Aires, Argentina

Clinica La Sagrada Familia

Ciudad Autonoma Buenos Aires, Argentina

Fundacion para la Lucha contra las Enfermedades Neurologicas de la Infancia - FLENI

Ciudad Autonoma Buenos Aires, Argentina

Complejo Medico de la Policia Federal Argentina Churruca Visca

Ciudad Autonoma Buenos Aires, Argentina

Clinica Privada Velez Sarfield

Córdoba, Argentina

Nuevo Hospital San Roque

Córdoba, Argentina

Sanatorio Allende

Córdoba, Argentina

Sanatorio Privado Duarte Quiros De Clinica Colombo SA

Córdoba, Argentina

Sanatorio de la Canada

Córdoba, Argentina

Hospital Cordoba

Córdoba, Argentina

Hospital Privado de Comunidad

Mar del Plata, Argentina

Hospital Universitario Austral

Pilar, Argentina

Hospital Privado de Rosario

Rosario, Argentina

Campbelltown Hospital

Campbelltown, New South Wales, Australia

Liverpool Hospital

Liverpool, New South Wales, Australia

John Hunter Hospital

New Lambton Heights, New South Wales, Australia

Royal Adelaide Hospital

Adelaide, South Australia, Australia

Eastern Health-Box Hill Hospital

Box Hill, Victoria, Australia

Monash Medical Centre

Clayton, Victoria, Australia

Royal Melbourne Hospital

Parkville, Victoria, Australia

MHAT "Puls" AD

Blagoevgrad, Bulgaria

MHAT Blagoevgrad, EOOD

Blagoevgrad, Bulgaria

MHAT Heart and brain

Burgas, Bulgaria

MHAT Sv. Ivan Rilski EOOD

Gorna Oryahovitsa, Bulgaria

MHAT City Clinic Saint Georgi Ltd

Montana, Bulgaria

MHAT Heart and brain

Pleven, Bulgaria

University Multiprofile Hospital For Active Treatment Dr. Georgi Stranski EAD

Pleven, Bulgaria

UMHAT "Kaspela", EOOD

Plovdiv, Bulgaria

UMHAT "Sv. Georgi", EAD

Plovdiv, Bulgaria

UMHAT Kanev AD

Rousse, Bulgaria

UMHAT "Medika Ruse" OOD

Rousse, Bulgaria

Multiprofile Hospital For Active Treatment Hadji Dimitar OOD

Silven, Bulgaria

MHATNP "Sv. Naum" EAD

Sofia, Bulgaria

University First MHAT-Sofia "St. Joan Krastitel" EAD

Sofia, Bulgaria

Acibadem City Clinic Tokuda University Hospital EAD

Sofia, Bulgaria

Medical Military Academy MHAT Sofia

Sofia, Bulgaria

Multiprofile Hospital MHATEM 'Pirogov', Sofia

Sofia, Bulgaria

University Hospital St. Anna

Sofia, Bulgaria

MHAT 'Sv. Anna - Varna' AD

Varna, Bulgaria

The People's Hospital of Anyang City

Anyang, China

Baoji Central Hospital

Baoji, China

Inner Mongolia Baogang Hospital

Baotou, China

Cap Med University

Beijing, China

Peking University Third Hospital

Beijing, China

Hebei Cangzhou Central Hospital

Cangzhou, China

Jilin Cancer Hospital

Changchun, China

Hunan Provincial People's Hospital

Changsha, China

Chengdu Second People's Hospital

Chengdu, China

Chifeng Traditional Chinese and Mongolian Medicine Hospital

Chifeng, China

Daqing Longnan Hospital

Daqing, China

Daqing Oilfield General Hospital

Daqing, China

The First People's Hospital of Foshan

Foshan, China

General Hospital of Fushun Mining Bureau

Fushun, China

Third Affiliated Hospital of Guangzhou Medical University

Guangzhou, China

The Second Hospital of Harbin Medical University

Haerbin, China

The First Affiliated Hospital of University of South China

Hengyang, China

Huai'an Second People's Hospital

Huai'an, China

Huizhou Central People's Hospital

Huizhou, China

Huizhou First Hospital

Huizhou, China

Meihekou Central Hospital

Jilin City, China

Jinhua Municipal Central Hospital

Jinhua, China

Jining No.1 People's Hospital

Jining, China

Affiliated Hospital of Jiujiang University

Jiujiang, China

First People's Hospital of Yunnan Province

Kunming, China

Liaocheng People's Hospital

Liaocheng, China

Linfen Central Hospital

Linfen, China

Linyi People's Hospital

Linyi, China

Lu'an People's Hospital

Lu'an, China

The Second Affiliated Hospital of Henan University of Science and Technology

Luoyang, China

Luoyang Central Hospital

Luoyang, China

The Second Affiliated Hospital of Nanjing Medical University

Nanjing, China

Nanyang Central Hospital

Nanyang, China

Nanyang Nanshi Hospital

Nanyang, China

Ordos Central Hostipal

Ordos, China

Pingxiang People's Hospital

Pingxiang, China

Qingdao Central Hospital

Qingdao, China

Qingdao Municipal Hospital

Qingdao, China

Huashan Hospital, Fudan University

Shanghai, China

Shanghai Tenth People's Hospital

Shanghai, China

Shangrao People's Hospital

Shangrao, China

Yuebei People's Hospital

Shaoguan, China

Affiliated Central Hospital of Shenyang Medical College

Shenyang, China

The First People's Hospital of Shenyang

Shenyang, China

Hebei General Hospital

Shijiazhuang, China

The Second Hospital of Hebei Medical University

Shijiazhuang, China

Shiyan Taihe Hospital

Shiyan, China

Sichuan Provincial People's Hospital

Sichuan, China

Shanxi Cardiovascular Hospital

Taiyuan, China

The First People's Hospital of Tancheng

Tengzhou, China

Weifang People's Hospital

Weifang, China

The First Affiliated Hospital of Wenzhou Medical University

Wenzhou, China

The Central Hospital of Wuhan

Wuhan, China

Wuhan Puai Hospital

Wuhan, China

Xinxiang Central Hospital

Xinxiang, China

The People's Hospital Of Xuancheng City

Xuancheng, China

Xuzhou Central Hospital

Xuzhou, China

Yantai Yuhuangding Hospital

Yantai, China

And 157 more locations on ClinicalTrials.gov